We've found
10,154
archived clinical trials in
Other Indications
We've found
10,154
archived clinical trials in
Other Indications
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Click here to add this to my saved trials

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Click here to add this to my saved trials

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Click here to add this to my saved trials

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Click here to add this to my saved trials

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Click here to add this to my saved trials

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Click here to add this to my saved trials

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Click here to add this to my saved trials

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Click here to add this to my saved trials

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Click here to add this to my saved trials

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Updated: 3/13/2018
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Click here to add this to my saved trials

Vitamin D Repletion in Primary Hyperparathyroidism
Updated: 3/15/2018
Randomized Controlled Trial of Vitamin D Repletion Regimens in Primary Hyperparathyroidism
Status: Enrolling
Updated: 3/15/2018
Vitamin D Repletion in Primary Hyperparathyroidism
Updated: 3/15/2018
Randomized Controlled Trial of Vitamin D Repletion Regimens in Primary Hyperparathyroidism
Status: Enrolling
Updated: 3/15/2018
Click here to add this to my saved trials

Reducing Postoperative Catheterization
Updated: 3/15/2018
Reducing Postoperative Catheterization After Urogynecology Surgery: A Randomized Trial
Status: Enrolling
Updated: 3/15/2018
Reducing Postoperative Catheterization
Updated: 3/15/2018
Reducing Postoperative Catheterization After Urogynecology Surgery: A Randomized Trial
Status: Enrolling
Updated: 3/15/2018
Click here to add this to my saved trials

NAC Trial for Anosmia
Updated: 3/16/2018
Pilot Study of Topical Intranasal N-acetyl Cysteine Administration for the Treatment of Anosmia
Status: Enrolling
Updated: 3/16/2018
NAC Trial for Anosmia
Updated: 3/16/2018
Pilot Study of Topical Intranasal N-acetyl Cysteine Administration for the Treatment of Anosmia
Status: Enrolling
Updated: 3/16/2018
Click here to add this to my saved trials

Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men
Updated: 3/16/2018
Effect of Prostatic Urethral Lift (PUL) Versus Prostate Arterial Embolization (PAE),Novel Minimally Invasive Treatment Options on Health-related Quality of Life (HRQoL) in Men With Lower Urinary Tract Symptoms Secondary to BPH.
Status: Enrolling
Updated: 3/16/2018
Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men
Updated: 3/16/2018
Effect of Prostatic Urethral Lift (PUL) Versus Prostate Arterial Embolization (PAE),Novel Minimally Invasive Treatment Options on Health-related Quality of Life (HRQoL) in Men With Lower Urinary Tract Symptoms Secondary to BPH.
Status: Enrolling
Updated: 3/16/2018
Click here to add this to my saved trials

Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms
Updated: 3/19/2018
Urinary Nerve Growth Factor as a Biomarker for Medical Treatment of Male Lower Urinary Tract Symptoms: A Pilot Trial
Status: Enrolling
Updated: 3/19/2018
Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms
Updated: 3/19/2018
Urinary Nerve Growth Factor as a Biomarker for Medical Treatment of Male Lower Urinary Tract Symptoms: A Pilot Trial
Status: Enrolling
Updated: 3/19/2018
Click here to add this to my saved trials

Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS
Updated: 3/19/2018
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome
Status: Enrolling
Updated: 3/19/2018
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS
Updated: 3/19/2018
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome
Status: Enrolling
Updated: 3/19/2018
Click here to add this to my saved trials

Vitamin D Repletion and Maintenance in IBD: How Much and How Often
Updated: 3/19/2018
A Vitamin D Dosing Strategy for Adequate Repletion and Maintenance in IBD Patients With Minimal Disease Activity
Status: Enrolling
Updated: 3/19/2018
Vitamin D Repletion and Maintenance in IBD: How Much and How Often
Updated: 3/19/2018
A Vitamin D Dosing Strategy for Adequate Repletion and Maintenance in IBD Patients With Minimal Disease Activity
Status: Enrolling
Updated: 3/19/2018
Click here to add this to my saved trials

Human Brain Antioxidants During Oxidative Stress
Updated: 3/20/2018
Noninvasive Antioxidant Quantification in the Human Brain Under Oxidative Stress
Status: Enrolling
Updated: 3/20/2018
Human Brain Antioxidants During Oxidative Stress
Updated: 3/20/2018
Noninvasive Antioxidant Quantification in the Human Brain Under Oxidative Stress
Status: Enrolling
Updated: 3/20/2018
Click here to add this to my saved trials

Human Brain Antioxidants During Oxidative Stress
Updated: 3/20/2018
Noninvasive Antioxidant Quantification in the Human Brain Under Oxidative Stress
Status: Enrolling
Updated: 3/20/2018
Human Brain Antioxidants During Oxidative Stress
Updated: 3/20/2018
Noninvasive Antioxidant Quantification in the Human Brain Under Oxidative Stress
Status: Enrolling
Updated: 3/20/2018
Click here to add this to my saved trials

TEACH: Technology Evaluation to Address Child Health
Updated: 3/20/2018
TEACH: Technology Evaluation to Address Child Health
Status: Enrolling
Updated: 3/20/2018
TEACH: Technology Evaluation to Address Child Health
Updated: 3/20/2018
TEACH: Technology Evaluation to Address Child Health
Status: Enrolling
Updated: 3/20/2018
Click here to add this to my saved trials

Vitamin D Replacement After Kidney Transplant
Updated: 3/21/2018
Vitamin D Replacement After Kidney Transplant
Status: Enrolling
Updated: 3/21/2018
Vitamin D Replacement After Kidney Transplant
Updated: 3/21/2018
Vitamin D Replacement After Kidney Transplant
Status: Enrolling
Updated: 3/21/2018
Click here to add this to my saved trials

Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
Updated: 3/21/2018
RAD 1203: Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
Updated: 3/21/2018
RAD 1203: Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Click here to add this to my saved trials

Treatment of Rett Syndrome With Recombinant Human IGF-1
Updated: 3/23/2018
Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)
Status: Enrolling
Updated: 3/23/2018
Treatment of Rett Syndrome With Recombinant Human IGF-1
Updated: 3/23/2018
Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)
Status: Enrolling
Updated: 3/23/2018
Click here to add this to my saved trials

Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis
Updated: 3/23/2018
A Randomized Pilot Trial of Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis
Status: Enrolling
Updated: 3/23/2018
Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis
Updated: 3/23/2018
A Randomized Pilot Trial of Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis
Status: Enrolling
Updated: 3/23/2018
Click here to add this to my saved trials

Community-Led Action Research in Oncology: Improving Symptom Management
Updated: 3/23/2018
Community-Led Action Research in Oncology: Improving Symptom Management
Status: Enrolling
Updated: 3/23/2018
Community-Led Action Research in Oncology: Improving Symptom Management
Updated: 3/23/2018
Community-Led Action Research in Oncology: Improving Symptom Management
Status: Enrolling
Updated: 3/23/2018
Click here to add this to my saved trials

Community-Led Action Research in Oncology: Improving Symptom Management
Updated: 3/23/2018
Community-Led Action Research in Oncology: Improving Symptom Management
Status: Enrolling
Updated: 3/23/2018
Community-Led Action Research in Oncology: Improving Symptom Management
Updated: 3/23/2018
Community-Led Action Research in Oncology: Improving Symptom Management
Status: Enrolling
Updated: 3/23/2018
Click here to add this to my saved trials

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Updated: 3/23/2018
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Status: Enrolling
Updated: 3/23/2018
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Updated: 3/23/2018
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Status: Enrolling
Updated: 3/23/2018
Click here to add this to my saved trials

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Updated: 3/23/2018
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Status: Enrolling
Updated: 3/23/2018
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Updated: 3/23/2018
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Status: Enrolling
Updated: 3/23/2018
Click here to add this to my saved trials

Caregiver Burden and Distress in Hematopoeitic Stem Cell Transplant
Updated: 3/27/2018
The Impact of Hematopoeitic Stem Cell Transplantation on Primary Caregiver Level of Burden and Distress
Status: Enrolling
Updated: 3/27/2018
Caregiver Burden and Distress in Hematopoeitic Stem Cell Transplant
Updated: 3/27/2018
The Impact of Hematopoeitic Stem Cell Transplantation on Primary Caregiver Level of Burden and Distress
Status: Enrolling
Updated: 3/27/2018
Click here to add this to my saved trials

Maximizing Language Development in Children With Hearing Loss
Updated: 3/27/2018
Pre-Implantation Communication Treatment for Children With Hearing Loss
Status: Enrolling
Updated: 3/27/2018
Maximizing Language Development in Children With Hearing Loss
Updated: 3/27/2018
Pre-Implantation Communication Treatment for Children With Hearing Loss
Status: Enrolling
Updated: 3/27/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Updated: 3/28/2018
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Click here to add this to my saved trials
